Science Explorer Interactive view Map
Company · Uppsala · Sweden

Ilya Pharma (Sweden)

ilyapharma.seROR OpenAlex
Research works
5
▲ 1015% vs 2013–17
Citations
137
28.8 per fractional work
Top-10% rate
25.8%
record average 16.5%
Open access
60%
world 28%

Not ranked overall: Ilya Pharma (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Ilya Pharma (Sweden) publish most on?

By volume in 2022–2025: Virus-based gene therapy research, CAR-T cell therapy research, Cancer Research and Treatments and Immune Response and Inflammation.

Virus-based gene therapy…0Virus-based gene therapy research: 0 fractional worksCAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional worksCancer Research and Treatments: 0 fractional worksImmune Response and Inflammation: 0 fractional worksAntimicrobial Peptides and Activities: 0 fractional worksWound Healing and Treatments: 0 fractional worksProbiotics and Fermented…0Probiotics and Fermented Foods: 0 fractional worksViral gastroenteritis research and epidemiology: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksChemokine receptors and signaling: 0 fractional works
GeneticsOncologyBiotechnologyImmunology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Virus-based gene therapy research Genetics 0 works
  2. 2 CAR-T cell therapy research Oncology 0 works
  3. 3 Cancer Research and Treatments Biotechnology 0 works
  4. 4 Immune Response and Inflammation Immunology 0 works
  5. 5 Antimicrobial Peptides and Activities Microbiology 0 works
  6. 6 Wound Healing and Treatments Rehabilitation 0 works
  7. 7 Probiotics and Fermented Foods Food Science 0 works
  8. 8 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
  9. 9 Immunotherapy and Immune Responses Immunology 0 works
  10. 10 Chemokine receptors and signaling Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available59.7%not open40.3%

World: 28% of research is openly available.

with international co-authors14.6%domestic only85.4%

World: 19% is written across borders.

How has Ilya Pharma (Sweden)'s research output changed?

Output in 2018–2022 was 1015% higher than in 2013–2017.

2020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Uppsala

All research institutions in Uppsala

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.